Science X2 signals: big pharmas, stem cells, mobile MRI
Posted by attilacsordas on September 27, 2008
The Institute for the Future‘s X2 project is all about tracing future trends in science and technology As the steward of the Biomedical Sciences and Biotechnology Group I collect signals in these fields on which some forecasts can be based later on. Here are some issues I found future sensitive enough recently:
GlaxoSmithKline collaborates with the Harvard Stem Cell Institute
Pfizer’s growing and various interests in stem cells
Regaining vision with gene therapy using adeno-associated viruses
Lightweight, open, mobile, cheaper MRI brain scanner prototype working in lab
The ‘stem cell matrix’:classifying stem cell lines based on global gene expression profiles
3 Responses to “Science X2 signals: big pharmas, stem cells, mobile MRI”
Sorry, the comment form is closed at this time.
Mstudent said
It seems there is a surge around adenovirus related technologies lately: safe gene therapy, safe iPS cells….
BTW: whatever happened to those projects aimed at creating artificial vectors for this kind of tampering?
Postcard said
I’m interseting in stem cells.
Nendoriod said
Hi!
I think it very good.I’m interseting in stem cells too.